JOSÉ ANTONIO
MARTÍNEZ ORGADO
Profesor asociado de Ciencias de la Salud
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (7)
2022
-
Regulation of Expression of Cannabinoid CB2 and Serotonin 5HT1A Receptor Complexes by Cannabinoids in Animal Models of Hypoxia and in Oxygen/Glucose-Deprived Neurons
International journal of molecular sciences, Vol. 23, Núm. 17
2019
-
Cannabidiol administration prevents hypoxia-ischemia-induced hypomyelination in newborn rats
Frontiers in Pharmacology, Vol. 10, Núm. SEP
2018
-
Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders
Biochemical Pharmacology, Vol. 157, pp. 85-96
2015
-
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
Neurotherapeutics, Vol. 12, Núm. 4, pp. 793-806
2013
-
Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?
British Journal of Clinical Pharmacology, Vol. 75, Núm. 2, pp. 323-333
2012
-
Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function
Neuropharmacology, Vol. 63, Núm. 5, pp. 776-783
2010
-
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors
Neurobiology of Disease, Vol. 37, Núm. 2, pp. 434-440